BeOne Medicines
ONC
#717
Rank
A$47.29 B
Marketcap
A$411.79
Share price
2.20%
Change (1 day)
-1.18%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): A$0.71 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are A$5.34 Billion. , an increase over its 2024 earnings that were of -A$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 A$0.69 B-183.61%
2024 -A$0.83 Billion-52.95%
2023 -A$1.76 Billion-32.52%
2022 -A$2.61 Billion24.39%
2021 -A$2.1 Billion-13.21%
2020 -A$2.42 Billion72.69%
2019 -A$1.4 Billion36.01%
2018 -A$1.03 Billion616.83%
2017 -A$0.15 Billion-15.24%
2016 -A$0.17 Billion107.91%
2015 -A$81.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.42 Million-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA